Literature DB >> 23468487

Ebola virus does not block apoptotic signaling pathways.

Judith Olejnik1, Jesus Alonso, Kristina M Schmidt, Zhen Yan, Wei Wang, Andrea Marzi, Hideki Ebihara, Jinghua Yang, Jean L Patterson, Elena Ryabchikova, Elke Mühlberger.   

Abstract

Since viruses rely on functional cellular machinery for efficient propagation, apoptosis is an important mechanism to fight viral infections. In this study, we sought to determine the mechanism of cell death caused by Ebola virus (EBOV) infection by assaying for multiple stages of apoptosis and hallmarks of necrosis. Our data indicate that EBOV does not induce apoptosis in infected cells but rather leads to a nonapoptotic form of cell death. Ultrastructural analysis confirmed necrotic cell death of EBOV-infected cells. To investigate if EBOV blocks the induction of apoptosis, infected cells were treated with different apoptosis-inducing agents. Surprisingly, EBOV-infected cells remained sensitive to apoptosis induced by external stimuli. Neither receptor- nor mitochondrion-mediated apoptosis signaling was inhibited in EBOV infection. Although double-stranded RNA (dsRNA)-induced activation of protein kinase R (PKR) was blocked in EBOV-infected cells, induction of apoptosis mediated by dsRNA was not suppressed. When EBOV-infected cells were treated with dsRNA-dependent caspase recruiter (dsCARE), an antiviral protein that selectively induces apoptosis in cells containing dsRNA, virus titers were strongly reduced. These data show that the inability of EBOV to block apoptotic pathways may open up new strategies toward the development of antiviral therapeutics.

Entities:  

Mesh:

Year:  2013        PMID: 23468487      PMCID: PMC3648168          DOI: 10.1128/JVI.01461-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  78 in total

1.  Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production.

Authors:  J M Emeny; M J Morgan
Journal:  J Gen Virol       Date:  1979-04       Impact factor: 3.891

2.  Evaluation of perceived threat differences posed by filovirus variants.

Authors:  Jens H Kuhn; Lori E Dodd; Victoria Wahl-Jensen; Sheli R Radoshitzky; Sina Bavari; Peter B Jahrling
Journal:  Biosecur Bioterror       Date:  2011-11-09

3.  Ebola virus infection in guinea pigs: presumable role of granulomatous inflammation in pathogenesis.

Authors:  E Ryabchikova; L Kolesnikova; M Smolina; V Tkachev; L Pereboeva; S Baranova; A Grazhdantseva; Y Rassadkin
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

4.  Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis.

Authors:  Nadia Wauquier; Pierre Becquart; Cindy Padilla; Sylvain Baize; Eric M Leroy
Journal:  PLoS Negl Trop Dis       Date:  2010-10-05

Review 5.  Following TRAIL's path in the immune system.

Authors:  Christina Falschlehner; Uta Schaefer; Henning Walczak
Journal:  Immunology       Date:  2009-06       Impact factor: 7.397

6.  Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation.

Authors:  Young Sik Cho; Sreerupa Challa; David Moquin; Ryan Genga; Tathagat Dutta Ray; Melissa Guildford; Francis Ka-Ming Chan
Journal:  Cell       Date:  2009-06-12       Impact factor: 41.582

7.  PARP-1 cleavage fragments: signatures of cell-death proteases in neurodegeneration.

Authors:  Ganta Vijay Chaitanya; Alexander J Steven; Phanithi Prakash Babu
Journal:  Cell Commun Signal       Date:  2010-12-22       Impact factor: 5.712

8.  HIV infection enhances TRAIL-induced cell death in macrophage by down-regulating decoy receptor expression and generation of reactive oxygen species.

Authors:  Dan-Ming Zhu; Juan Shi; Shilian Liu; Yanxin Liu; Dexian Zheng
Journal:  PLoS One       Date:  2011-04-05       Impact factor: 3.240

Review 9.  Intracellular events and cell fate in filovirus infection.

Authors:  Judith Olejnik; Elena Ryabchikova; Ronald B Corley; Elke Mühlberger
Journal:  Viruses       Date:  2011-08       Impact factor: 5.048

10.  Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery.

Authors:  Tsung-Hsien Chang; Toru Kubota; Mayumi Matsuoka; Steven Jones; Steven B Bradfute; Mike Bray; Keiko Ozato
Journal:  PLoS Pathog       Date:  2009-06-26       Impact factor: 6.823

View more
  18 in total

Review 1.  Filovirus Strategies to Escape Antiviral Responses.

Authors:  Judith Olejnik; Adam J Hume; Daisy W Leung; Gaya K Amarasinghe; Christopher F Basler; Elke Mühlberger
Journal:  Curr Top Microbiol Immunol       Date:  2017       Impact factor: 4.291

Review 2.  The multiple roles of sGP in Ebola pathogenesis.

Authors:  Marc-Antoine de La Vega; Gary Wong; Gary P Kobinger; Xiangguo Qiu
Journal:  Viral Immunol       Date:  2015-02       Impact factor: 2.257

3.  Role of Transmembrane Protein 16F in the Incorporation of Phosphatidylserine Into Budding Ebola Virus Virions.

Authors:  Patrick Younan; Mathieu Iampietro; Rodrigo I Santos; Palaniappan Ramanathan; Vsevolod L Popov; Alexander Bukreyev
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

4.  Ebola Virus Does Not Induce Stress Granule Formation during Infection and Sequesters Stress Granule Proteins within Viral Inclusions.

Authors:  Emily V Nelson; Kristina M Schmidt; Laure R Deflubé; Sultan Doğanay; Logan Banadyga; Judith Olejnik; Adam J Hume; Elena Ryabchikova; Hideki Ebihara; Nancy Kedersha; Taekjip Ha; Elke Mühlberger
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

5.  Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus.

Authors:  Kang Yiu Lai; Wing Yiu George Ng; Fan Fanny Cheng
Journal:  Infect Dis Poverty       Date:  2014-11-28       Impact factor: 4.520

Review 6.  Molecular mechanisms of Ebola virus pathogenesis: focus on cell death.

Authors:  L Falasca; C Agrati; N Petrosillo; A Di Caro; M R Capobianchi; G Ippolito; M Piacentini
Journal:  Cell Death Differ       Date:  2015-05-29       Impact factor: 15.828

Review 7.  Phosphatidylserine receptors: enhancers of enveloped virus entry and infection.

Authors:  Sven Moller-Tank; Wendy Maury
Journal:  Virology       Date:  2014-09-29       Impact factor: 3.616

8.  Differential transcriptional responses to Ebola and Marburg virus infection in bat and human cells.

Authors:  Martin Hölzer; Verena Krähling; Fabian Amman; Emanuel Barth; Stephan H Bernhart; Victor A O Carmelo; Maximilian Collatz; Gero Doose; Florian Eggenhofer; Jan Ewald; Jörg Fallmann; Lasse M Feldhahn; Markus Fricke; Juliane Gebauer; Andreas J Gruber; Franziska Hufsky; Henrike Indrischek; Sabina Kanton; Jörg Linde; Nelly Mostajo; Roman Ochsenreiter; Konstantin Riege; Lorena Rivarola-Duarte; Abdullah H Sahyoun; Sita J Saunders; Stefan E Seemann; Andrea Tanzer; Bertram Vogel; Stefanie Wehner; Michael T Wolfinger; Rolf Backofen; Jan Gorodkin; Ivo Grosse; Ivo Hofacker; Steve Hoffmann; Christoph Kaleta; Peter F Stadler; Stephan Becker; Manja Marz
Journal:  Sci Rep       Date:  2016-10-07       Impact factor: 4.379

9.  Ebola Virus Requires Phosphatidylserine Scrambling Activity for Efficient Budding and Optimal Infectivity.

Authors:  Marissa D Acciani; Maria F Lay Mendoza; Katherine E Havranek; Avery M Duncan; Hersha Iyer; Olivia L Linn; Melinda A Brindley
Journal:  J Virol       Date:  2021-07-28       Impact factor: 5.103

10.  Activation of innate antiviral immune response via double-stranded RNA-dependent RLR receptor-mediated necroptosis.

Authors:  Wei Wang; Wei-Hua Wang; Kazem M Azadzoi; Ning Su; Peng Dai; Jianbin Sun; Qin Wang; Ping Liang; Wentao Zhang; Xiaoying Lei; Zhen Yan; Jing-Hua Yang
Journal:  Sci Rep       Date:  2016-03-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.